A severe but reversible refractory sprue [6]

Gut

Volumn 55, Issue 8, 2006, Pages 1210-1211

  Dray, X ^a   Joly, F ^b   Lavergne Slove, A ^a   Treton, X ^b   Bouhnik, Y ^b   Messing, B ^b  

^a HÔPITAL LARIBOISIÈRE   (France)

^b BEAUJON HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE; OMEPRAZOLE; PENTOSTATIN;

ADULT; ANAMNESIS; CASE REPORT; CLINICAL FEATURE; DRUG EFFECT; GASTROINTESTINAL DISEASE; HUMAN; JEJUNUM ULCER; LETTER; MALE; PARENTERAL NUTRITION; PRIORITY JOURNAL; REFRACTORY SPRUE; TREATMENT OUTCOME;

ADULT; CELIAC DISEASE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; JEJUNAL DISEASES; MALE; PENTOSTATIN;

EID: 33746120836     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2005.089987     Document Type: Letter

References (13)

1. Longstreth GF. Successful treatment of refractory sprue with cyclosporine. Ann Intern Med 1993;119:1014-16.
2. Vaidya A, Bolanos J, Berkelhammer C. Azamioprine in refractory sprue. Am J Gastroenterol 1999;94:1967-9.
3. Rolny P, Sigurjonsdottir HA, Remotti M, et al. Role of immunosuppressive therapy in refractory sprue-like disease. Am J Gastroenterol 1999;94:219-25.
4. Wahab PJ, Crusius JB, Meijer JW, et al. Cyclosporin in the treatment of adults with refractory coeliac disease-an open pilot study. Aliment Pharmacol Ther 2000;14:767-74.
5. Mulder CJ, Wahab PJ, Meijer JW, et al. A pilot study of recombinant human interleukin-10 in adults with refractory coeliac disease. Eur J Gastroenterol Hepatol 2001;13:1183-8.
6. Maurino E, Niveloni S, Chernavsky A, et al. Azathioprine in refractory sprue: results from a prospective, open-label study. Am J Gastroenterol 2002;97:2595-602.
7. Gillett HR, Arnott ID, McIntyre M, et al. Successful infliximab treatment for steroid-refractory celiac disease: a case report. Gastroenterology 2002;122:800-5.
8. Goerres MS, Meijer JW, Wahab PJ, et al. Azathioprine ana prednisone combination therapy in refractory coeliac disease. Aliment Pharmacol Ther 2003;18:487-94.
9. Crenn P, Vahedi K, Lavergne-Slove A, et al. Plasma citrulline: A marker of enterocyte mass in villous atrophy-associated small bowel disease. Gastroenterology 2003;124:1210-19.
10. Jehn U, Bartl R, Dietzfelbinger H, et al. An update: 12-year follow-up of patients with hairy cell leukemia following treatment with 2- chlorodeoxyadenosine. Leukemia 2004;18:1476-81.
11. Dillman RO. Pentostatin (Nipent) in the treatment of chronic lymphocyte leukemia and hairy cell leukemia. Expert Rev Anticancer Ther 2004;4:27-36.
12. Corazzelli G, Capobianco G, Russo F, et al. Pentostatin (2′-deoxycoformycin) for the treatment of hepatosplenic gammadelta T-cell lymphomas. Haematologica 2005;90:ECR14.
13. Goerres MS, Wahab PJ, Kerckhaert JO, et al. Cladribine treatment in refractory coeliac disease type II. Digestive Diseases Week. Orlando, FL, USA, 18-22 May 2003.